The Sophie Atay Appeal





Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Jun 14, 2009

The Sophie Atay Neuroblastoma Appeal - Please Read!

Sophie is a gorgeous, inspiring little girl who I had the pleasure of looking after for over a year in her private day care nursery. It is devastating to know that she has been affected by such an aggressive killer disease at such a young age. I am trying to help the family as much as I am physically able to raise awareness about this type of cancer and to hopefully raise enough money to give this little angel the best possible chance of survival. I know many of you may be parents yourselves, but this kind of news would surely even tug severely at the less paternal types of peoples heart strings... or so it should??
She was just 15 months old. Neuroblastoma is a rare and aggressive malignant cancer with horrendous survival rates as low as 20%. Relapse is very common which is reflected in the survival rate. If relapse does occur there is no cure at the moment in the UK.
After extensively searching through the current treatments available, an option for Sophie would be to have a monoclonal antibody known as 3f8 at the same time as she has her Accutane (oral chemotherapy). Combined, this treatment gives Sophie a staggering 80-90% of survival. The huge downside of this is that the only place in the world that offers this treatment is a hospital in New York called Memorial Sloan Kettering Hospital. The cost for this treatment alone can be in excess of $500,000.
Fewer than 100 children are diagnosed with neuroblastoma in the UK each year. Most children who get this cancer are younger than five years old. Neuroblastoma is the second most common solid tumour in childhood and makes up 8% of the total number of children's cancers.



Please also join my facebook group: The Sophie Atay Appeal


When autoplay is enabled, a suggested video will automatically play next.

Up Next

Sign in to add this to Watch Later

Add to